Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SmartCella Holding AB logo — SmartCella is a global biopharma company with a vision to re...

SmartCella Holding AB

SmartCella is a global biopharma company with a vision to revolutionize targeted therapeutic delivery.

Founded 2014 Sweden Sweden 72 employees Unknown Total: $378.00M Biotechnology, Health Care +2

General Information

Company Name SmartCella Holding AB
Founded Year 2014
Location Sweden Sweden +1
Employees 72
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Unknown
Social

Get notified when SmartCella Holding AB moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SmartCella Holding AB

SmartCella Holding AB is a biopharmaceutical company aiming to revolutionize targeted therapeutic delivery with cutting-edge solutions. Founded in 2014 and based in Sweden, the company is rooted in world-class science and research from Karolinska Institutet.

Operating in the Biotechnology and Health Care sectors, SmartCella focuses on two key areas: Targeted Delivery and Regenerative Medicines. Their flagship product, the Extroducer®, is a novel endovascular delivery device facilitating targeted therapeutic delivery to challenging areas like hard-to-reach organs and tumors. This innovation underscores their commitment to developing therapies for difficult-to-treat diseases.

Recently, SmartCella secured a significant €50.00M in a Private Equity Round on 08 July 2024, attracting prominent investors such as AP4, Swedish pension fund AMF, SEB, RoosGruppen, AstraZeneca, and Handelsbanken Fonder. This funding highlights substantial investor confidence in their potential to deliver life-changing treatments globally.

Taxonomy: Biopharma, Targeted Therapeutic Delivery, Biotech Methods, Medical Science, Living Systems Therapies, Difficult-to-Treat Diseases, Delivery Solutions, Therapy Development, Karolinska Institutet, Novel Delivery Platforms, Endovascular Delivery Device, Cell Therapies Manufacturing, Targeted Delivery, Regenerative Medicines, Cardiac Disease Therapies

Services & Products

Device-based Delivery
Cell Therapies
Modified Cell Therapies

Target Customers

Patients in need of advanced therapies Healthcare Providers Medical Researchers Biotech Innovators

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Late Vc •••••• 5
Investor Investor
•••• •••• 		01 Jul 2024
Early VC •••••• 8
Investor Investor Investor Investor
•••• •••• 		01 Sep 2021

SmartCella Holding AB Alternatives & Competitors

View All Alternatives
SmartCella Holding AB vs
Hexagon Bio
Hexagon Bio United States

Discovering novel medicines in the global metagenome and bringing them to patients

Series B
75 employees
Biotechnology, Health Care
Compare SmartCella Holding AB vs Hexagon Bio
SmartCella Holding AB vs
Cerebral Therapeutics, Inc.
Cerebral Therapeutics, Inc. United States

A clinical stage pharmaceutical company developing innovative treatments for neurological disease.

Series C
22 employees
Biotechnology, Health Care
Compare SmartCella Holding AB vs Cerebral Therapeutics, Inc.
SmartCella Holding AB vs
Anchiano Therapeutics
Anchiano Therapeutics United States

Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat...

Post Ipo Equity
1 employees
Biotechnology, Health Care
Compare SmartCella Holding AB vs Anchiano Therapeutics
View all alternatives

FAQ About SmartCella Holding AB

SmartCella is a global biopharma company with a vision to revolutionize targeted therapeutic delivery.
SmartCella Holding AB was founded in 2014.
SmartCella Holding AB is headquartered in Sweden.
SmartCella Holding AB operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences.
SmartCella Holding AB has approximately 72 employees.
SmartCella Holding AB has completed 2 funding rounds, raising a total of $378.00M. The latest funding stage is Unknown.
SmartCella Holding AB offers: Device-based Delivery, Cell Therapies, Modified Cell Therapies.
Top alternatives and competitors to SmartCella Holding AB include Hexagon Bio, Cerebral Therapeutics, Inc., Anchiano Therapeutics, Ligandal, Orbital Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SmartCella Holding AB and Hexagon Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SmartCella Holding AB and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy